Our customers' Feedback
Search:
Perform search
Categories list

Buy Vaniqa

News
Vaniqa
Vaniqa photo

Buy Vaniqa (Eflornithine)

Skin Care, Women's Health

PackagePricePer pillSavingsOrder
13.9% 15g × 1 tube$69.95$69.95Add to cart
13.9% 15g × 2 tube$125.95$62.98$13.95Add to cart

Most popular quantity.

Products from the same category

Social bookmarks:
Choose your language:



Money backguarantee
Secureshopping

Our billing is certified by:

Secure shopping certificates

Special Offer!

  • Cipher Pharmaceuticals Inc (CPH) Downgraded by Bloom Burton to “Hold” - BNB Daily (blog)

    Cipher Pharmaceuticals Inc (CPH) Downgraded by Bloom Burton to “Hold”BNB Daily (blog)Cipher Pharmaceuticals Inc logo Bloom Burton lowered shares of Cipher Pharmaceuticals Inc (TSE:CPH) (NASDAQ:CPHR) from a buy rating to a hold rating in a research note released on Monday morning.

  • Cipher Pharmaceuticals Inc (CPH) Given New C$6.50 Price Target at TD Securities - BNB Daily (blog)

    Cipher Pharmaceuticals Inc (CPH) Given New C$6.

  • Cipher Pharmaceuticals (CPHR) Receives Daily Media Impact Score of 0.05 - BNB Daily (blog)

    Cipher Pharmaceuticals (CPHR) Receives Daily Media Impact Score of 0.

  • John Mull Buys 8500 Shares of Cipher Pharmaceuticals Inc (CPH) Stock - BNB Daily (blog)

    BNB Daily (blog)John Mull Buys 8500 Shares of Cipher Pharmaceuticals Inc (CPH) StockBNB Daily (blog)Cipher Pharmaceuticals logo Cipher Pharmaceuticals Inc (TSE:CPH) (NASDAQ:CPHR) insider John Mull acquired 8,500 shares of the firm's stock in a transaction dated Wednesday, June 28th.

  • Cipher Pharmaceuticals (CPHR) Getting Somewhat Favorable Press Coverage, Study Shows - Sports Perspectives

    Cipher Pharmaceuticals (CPHR) Getting Somewhat Favorable Press Coverage, Study ShowsSports PerspectivesCipher Pharmaceuticals logo News stories about Cipher Pharmaceuticals (NASDAQ:CPHR) (TSE:CPH) have been trending somewhat positive on Saturday, according to Accern Sentiment.

    Copyright © www.ohnerezeptfreikauf.com is an affiliate marketing website. All rights reserved.